Skip to main content

Change location

You are currently on the Mexico (Español) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (Español)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Mexico (Español)
  • Carreras
  • Media and News
  • Póngase en contacto con nosotros
    • Mexico (Español)
    • Somos Bracco
    • Nuestros negocios
    • Propósito y valores
    • Nuestra historia
    • Fundación Bracco
    • Responsabilidad
    • Nuestro portafolio
      • Rayos X / (TC)
      • Medios de contraste

        • Sulfato de Bario
        • Bario TC
        • Radiologia/Fluoroscopia
        • Iomeron
        • Iopamiro
        • Cat-Bario
      • Dispositivos médicos

        • Empower CTA+
        • Accesorios Bario
      • MRI
      • Medios de contraste

        • MultiHance
        • ProHance
      • Dispositivos médicos

        • EmpowerMR
        • MustKit MR
      • CEUS
      • Medios de contraste

        • Sonovue
    • Medicina nuclear
      • Cardiología intervencionista
      • Medios de contraste

        • Iomeron
        • Iopamiro
      • Dispositivos médicos

        • ACIST CVi
    • Cardiología
    • Soluciones digitales
    • Oncología
    • Cardiology
    • Innovación
    • Futuro digital
    • I+D
    • Los centros de Bracco
    • Herencia científica y patentes
    • Education
    • Proyectos de próxima generación
    • Bracco Global Academy
    • Nuestras alianzas
    • Eventos
  • Sostenibilidad
  • Our Stories
142 results found
Article
Diagnostic challenges of benign/incidental lesions at Liver MRI and CEUS It will address the topic of MR imaging of benign lesions.
MRI of the Liver
Article
Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”
Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence
Article
Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
Article
Bracco Imaging has won the Gold Medal from EcoVadis The company is now proudly sporting the EcoVadis gold medal for what it has managed to achieve in four key areas: environment, ethics, labour and human rights, sustainable procurement.
No image available
Article
Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires
Diana Bracco riceve la cittadinanza onoraria di Torviscosa
Article
Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.
Fulvio Renoldi Bracco Spin Torviscosa
Article
Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.
EUSOMII interview
Article
The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.
Bracco Joined the United Nations Global Compact
Article
ECR2024 Bracco@ECR2024, where education meets innovation to shape the future of medical imaging.
Bracco@ECR2024
Article
Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.
Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracco)
  • Load More

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • Somos Bracco
  • Nuestro portafolio
  • Innovación
  • Aprendiendo juntos
  • Our Stories
  • Farmacovigilancia/Tecnovigilancia
  • Protección de Datos

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Términos de Uso
  • Política de privacidad
  • Política de cookies
  • Aviso legal
  • for Bracco VPN users

Bracco Copyright © 2026 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182